- Home
- LNKB vs INGN Comparison
LNKB vs INGN Comparison
Compare LNKB & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNKB
- INGN
- Stock Information
- Founded
- LNKB 2018
- INGN 2001
- Country
- LNKB United States
- INGN United States
- Employees
- LNKB N/A
- INGN N/A
- Industry
- LNKB
- INGN Industrial Specialties
- Sector
- LNKB
- INGN Health Care
- Exchange
- LNKB Nasdaq
- INGN Nasdaq
- Market Cap
- LNKB 270.4M
- INGN 219.3M
- IPO Year
- LNKB N/A
- INGN 2014
- Fundamental
- Price
- LNKB $7.33
- INGN $8.42
- Analyst Decision
- LNKB Strong Buy
- INGN Strong Buy
- Analyst Count
- LNKB 1
- INGN 3
- Target Price
- LNKB $9.00
- INGN $11.00
- AVG Volume (30 Days)
- LNKB 34.3K
- INGN 182.8K
- Earning Date
- LNKB 10-27-2025
- INGN 11-06-2025
- Dividend Yield
- LNKB 4.10%
- INGN N/A
- EPS Growth
- LNKB N/A
- INGN N/A
- EPS
- LNKB 1.01
- INGN N/A
- Revenue
- LNKB $121,982,000.00
- INGN $343,472,000.00
- Revenue This Year
- LNKB $18.26
- INGN $7.68
- Revenue Next Year
- LNKB N/A
- INGN $6.47
- P/E Ratio
- LNKB $7.25
- INGN N/A
- Revenue Growth
- LNKB 79.01
- INGN 5.15
- 52 Week Low
- LNKB $6.09
- INGN $5.70
- 52 Week High
- LNKB $7.98
- INGN $12.91
- Technical
- Relative Strength Index (RSI)
- LNKB 55.01
- INGN 62.92
- Support Level
- LNKB $7.03
- INGN $8.40
- Resistance Level
- LNKB $7.38
- INGN $8.70
- Average True Range (ATR)
- LNKB 0.18
- INGN 0.31
- MACD
- LNKB 0.00
- INGN -0.00
- Stochastic Oscillator
- LNKB 66.67
- INGN 71.43
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.